Scientists Launch Trial To Test Long-Acting Antibody For Long Covid
With over 65 million people suffering globally, US scientists have begun a major clinical trial to test a monoclonal antibody that may finally treat the complex mystery of Long Covid.
May 04, 2025, 11:07 AM IST